Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fetal Lung Tissue Engineering Publisher Pubmed



Zolbin MM1 ; Daghigh F2, 3 ; Shojaie L1, 4 ; Ekhtiyari M1 ; Kajbafzadeh AM1, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Urology and Regenerative Medicine Research Center, Section of Tissue Engineering and Stem Cells, Therapy, Children’s Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Physiology, Tabriz Branch, Islamic Azad University, Tabriz, Iran
  3. 3. Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Department of Medicine Division of GI/Liver Keck School of Medicine, University of Southern California, Los Angeles, United States
  5. 5. No. 62, Dr. Gharib’s Street, Keshavarz Boulevard, (PANNEK, #6), Tehran, 1419433151, Iran

Source: Advances in Experimental Medicine and Biology Published:2021


Abstract

Lung transplantation may be considered as a final treatment option for diseases such as chronic lung disease, pulmonary hypertension, bronchopulmonary dysplasia, pulmonary fibrosis, and end-stage lung disease. The five-year survival rate of lung transplants is nearly 50%. Unfortunately, many patients will die before a suitable lung donor can be found. Importantly, the shortage of donor organs has been a significant problem in lung transplantation. The tissue engineering approach uses de- and recellularization of lung tissue to create functional lung substitutes to overcome donor lung limitations. Decellularization is hope for generating an intact ECM in the development of the engineered lung. The goal of decellularization is to prepare a suitable scaffold of lung tissue that contains an appropriate framework for the functionality of regenerated lung tissue. In this chapter, we aim to describe the decellularization protocols for lung tissue regenerative purposes. © 2021, Springer Nature Switzerland AG.
Other Related Docs
16. Decellularizing Bone Tissue: Various Protocols, Regenerative Engineering and Translational Medicine (2024)
18. Engineering Natural Heart Valves: Possibilities and Challenges, Journal of Tissue Engineering and Regenerative Medicine (2017)